nitroglycerin has been researched along with sildenafil citrate in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (10.87) | 18.2507 |
| 2000's | 30 (65.22) | 29.6817 |
| 2010's | 8 (17.39) | 24.3611 |
| 2020's | 3 (6.52) | 2.80 |
| Authors | Studies |
|---|---|
| McCarthy, D; Schwartz, I | 1 |
| Allen, MJ; Freestone, S; Muirhead, GJ; Webb, DJ | 1 |
| Arora, RR; Melilli, L; Timoney, M | 1 |
| Kloner, RA; Zusman, RM | 1 |
| Omote, M | 1 |
| Nakaki, T | 1 |
| Dinsmore, WW; Levi, R; Muirhead, GJ; Sutton, JA; Webb, DJ; Wulff, M | 1 |
| Walsh, R | 1 |
| Donahue, JK; Lawrence, JH; Marbán, E; Nagata, K | 1 |
| Kingma, JH; Meuleman, EJ | 1 |
| Bhalerao, S | 1 |
| Lee, TH | 1 |
| Hirose, R; Ichimura, M; Irie, J; Nomoto, Y; Ohno, T; Okumura, H; Onoda, Y; Takai, H; Yoshimatsu, A | 1 |
| Kim, HS; Lee, J; Moon, JD; Yoo, KY | 1 |
| Nichols, WW; O'Rourke, MF | 1 |
| Hisasue, S; Sato, Y; Tsukamoto, T | 1 |
| Bertel, O; Brunner-La Rocca, HP; Kiowski, W; Oechslin, E; Schad, K; Schalcher, C; Scharf, C; Schindler, R; Suetsch, G | 1 |
| Khandheria, BK | 1 |
| Mickley, H | 1 |
| Coleski, R; Gonlachanvit, S; Hasler, WL; Owyang, C | 1 |
| Kloner, RA | 2 |
| Beaver, TM; Hess, PJ; Klodell, CT; Lobato, EB; Martin, TD; Staples, ED; Trachte, AL; Urdaneta, F | 1 |
| Brixius, K; Diedrichs, H; Halbach, R; Rosenkranz, S; Schwinger, RH | 1 |
| Chou, E; Daoud, VP; Kukreja, RC; Ockaili, RA; Salloum, FN; Takenoshita, Y; Yoshida, K | 1 |
| Coelho, OR; Consolim-Colombo, FM; Ferreira-Melo, SE; Irigoyen, MC; Moreno, H; Yugar-Toledo, JC | 1 |
| Bart, BA; Glue, P; Jen, F; Koren, MJ; Malhotra, B; Parker, JD; Siegel, RL; Wang, H; Webb, DJ | 1 |
| Werns, SW | 1 |
| Chattipakorn, N; Chattipakorn, S; Shinlapawittayatorn, K; Sungnoon, R | 1 |
| Antunes, E; Priviero, FB; Teixeira, CE; Toque, HA; Webb, RC; Zemse, SM | 1 |
| Movsesian, MA; Stehlik, J | 1 |
| Kerr, DM; Oliver, JJ; Webb, DJ | 1 |
| Greenall, J; Hyland, S; Koczmara, C | 1 |
| Ambriz-Tututi, M; Araiza-Saldaña, CI; Caram-Salas, NL; Castañeda-Corral, G; Granados-Soto, V; Hong, E; Rocha-González, HI | 1 |
| Olesen, J | 1 |
| Everett, TR; Johal, T; Lees, CC; Wilkinson, IB | 1 |
| Gori, T; Liuni, A; Luca, MC; Lytvyn, Y; McLaughlin, K; Parker, JD | 1 |
| Carøe Nordgaard, J; Gammeltoft, S; Kruse, LS; Kruuse, CR | 1 |
| Franco, MJ; Galluzzo, RN; Gonçalves, LF; Pires, MM; Trapani, A; Trapani, TF | 1 |
| Baba, T; Iijima, S; Ohishi, A; Ueno, D | 1 |
| Berk-Krauss, J; Christman, MP; Franks, A; Liebman, TN; Sicco, KL | 1 |
| Elbasiouny, MS; Eldeen, OS; Ellabban, MA; Fattah, IOA; Hosny, H; Kader, GA; Khodeer, DM; Masadeh, S; Mehana, AE | 1 |
| Bergler-Czop, B; Brzezińska-Wcisło, L; Drobek, HH; Miziołek, B; Pietrauszka, K; Porwolik, M | 1 |
| Baker, PN; Ganzevoort, W; Gluud, C; Groom, KM; Jakobsen, JC; Kariya, CT; Kenny, LC; Leemhuis, AG; Magee, LA; Mol, BWJ; Papageorghiou, AT; Pels, A; Sharp, AN; von Dadelszen, P | 1 |
13 review(s) available for nitroglycerin and sildenafil citrate
| Article | Year |
|---|---|
Cardiovascular effects of sildenafil citrate and recommendations for its use.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Antihypertensive Agents; Blood Pressure; Contraindications; Drug Interactions; Erectile Dysfunction; Heart Diseases; Heart Rate; Humans; Male; Nitric Oxide; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Purines; Risk Factors; Sildenafil Citrate; Sulfones; United States; United States Food and Drug Administration; Vasodilator Agents | 1999 |
[Pharmacological profiles of sildenafil (VIAGRA) in the treatment of erectile dysfunction: efficacy and drug interaction with nitrate].
Topics: Animals; Blood Pressure; Cyclic GMP; Dogs; Drug Interactions; Erectile Dysfunction; Humans; Male; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Penile Erection; Penis; Phosphodiesterase Inhibitors; Piperazines; Purines; Rabbits; Sildenafil Citrate; Sulfones | 1999 |
[Nitic oxide and natriuretic peptides].
Topics: Adenylyl Cyclase Inhibitors; Aspirin; Cyclic GMP; Drug Design; Humans; Natriuretic Agents; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfhydryl Compounds; Sulfones | 2000 |
[Drug treatment of erection disorders in patients with cardiovascular disease].
Topics: Cardiovascular Diseases; Contraindications; Drug Interactions; Erectile Dysfunction; Humans; Isosorbide Dinitrate; Male; Netherlands; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Practice Guidelines as Topic; Purines; Sildenafil Citrate; Sulfones | 2001 |
[Adverse events and drug interactions of sildenafil].
Topics: Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Interactions; Erectile Dysfunction; Humans; Male; Nitroglycerin; Piperazines; Purines; Risk Factors; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2002 |
Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Arteriosclerosis; Blood Pressure; Carbolines; Contraindications; Coronary Disease; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Endothelium, Vascular; Erectile Dysfunction; Heart Rate; Humans; Hypotension; Imidazoles; Isosorbide Dinitrate; Male; Molecular Structure; Myocardial Infarction; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilation; Vasodilator Agents | 2004 |
Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
Topics: Adult; Aged; Cardiac Surgical Procedures; Drug Evaluation; Drug Resistance; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Milrinone; Nitric Oxide; Nitroglycerin; Nitroprusside; Phosphodiesterase Inhibitors; Piperazines; Postoperative Complications; Purines; Retrospective Studies; Sildenafil Citrate; Sulfones; Vascular Resistance; Vasodilator Agents | 2005 |
Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Erectile Dysfunction; Humans; Imidazoles; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2005 |
Nitric oxide-related drug targets in headache.
Topics: Cyclic GMP; Headache; Humans; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones | 2010 |
The nitric oxide pathway and possible therapeutic options in pre-eclampsia.
Topics: Aldehyde Oxidoreductases; Clinical Trials as Topic; Endothelium, Vascular; Female; Humans; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Pre-Eclampsia; Pregnancy; Purines; S-Nitrosothiols; Sildenafil Citrate; Sulfonamides | 2014 |
Hypertrophic pyloric stenosis following persistent pulmonary hypertension of the newborn: a case report and literature review.
Topics: Antihypertensive Agents; Atropine; Bosentan; Bronchodilator Agents; Female; High-Frequency Ventilation; Humans; Infant, Newborn; Meconium Aspiration Syndrome; Muscarinic Antagonists; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Persistent Fetal Circulation Syndrome; Pyloric Stenosis, Hypertrophic; Sildenafil Citrate; Vasodilator Agents | 2018 |
What is the Best Way to Treat Patients with Raynaud's Phenomenon and a Tendency towards Hypotension?
Topics: Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypotension; Losartan; Nifedipine; Nitroglycerin; Raynaud Disease; Sildenafil Citrate; Smoking Cessation; Stress, Psychological; Vasodilator Agents | 2020 |
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy.
Topics: Female; Fetal Death; Fetal Growth Retardation; Humans; Infant, Newborn; Nitric Oxide; Nitroglycerin; Placenta; Pregnancy; Premature Birth; Sildenafil Citrate; Tadalafil | 2023 |
8 trial(s) available for nitroglycerin and sildenafil citrate
| Article | Year |
|---|---|
Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Reference Values; Sildenafil Citrate; Sulfones; Vasodilator Agents | 1999 |
Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Aged; Angina Pectoris; Blood Pressure; Contraindications; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2000 |
Interaction of sildenafil with cAMP-mediated vasodilation in vivo.
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Brachial Artery; Cyclic AMP; Cyclic GMP; Forearm; Heart Rate; Hemodynamics; Humans; Isoproterenol; Male; Milrinone; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Regional Blood Flow; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents | 2002 |
Cyclic guanosine monophosphate phosphodiesterase-5 inhibitor promotes an endothelium NO-dependent-like vasodilation in patients with refractory hypertension.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Endothelium; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Signal Transduction; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents | 2007 |
Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
Topics: Aged; Aged, 80 and over; Blood Circulation; Coronary Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2007 |
Time-dependent interactions of the hypotensive effects of sildenafil citrate and sublingual glyceryl trinitrate.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Drug Interactions; Epidemiologic Methods; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Time Factors; Treatment Outcome; Vasodilator Agents | 2009 |
Repeated daily dosing with sildenafil provides sustained protection from endothelial dysfunction caused by ischemia and reperfusion: a human in vivo study.
Topics: Administration, Cutaneous; Adolescent; Adult; Biomarkers; Drug Administration Schedule; Endothelium, Vascular; Forearm; Healthy Volunteers; Hemodynamics; Humans; Male; Myoglobin; Nitroglycerin; P-Selectin; Peroxidase; Piperazines; Purines; Radial Artery; Reperfusion Injury; Sildenafil Citrate; Sulfones; Time Factors; Treatment Outcome; Vasodilator Agents; Young Adult | 2014 |
Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices.
Topics: Administration, Cutaneous; Adult; Blood Flow Velocity; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Middle Cerebral Artery; Nitroglycerin; Placental Insufficiency; Pregnancy; Prospective Studies; Pulsatile Flow; Sildenafil Citrate; Treatment Outcome; Ultrasonography, Prenatal; Umbilical Arteries; Uterine Artery; Vasodilator Agents; Young Adult | 2016 |
25 other study(ies) available for nitroglycerin and sildenafil citrate
| Article | Year |
|---|---|
Sildenafil in the treatment of erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Aged; Coitus; Contraindications; Drug Interactions; Erectile Dysfunction; Humans; Male; Myocardial Ischemia; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 1998 |
Acute myocardial infarction after the use of sildenafil.
Topics: Aged; Drug Therapy, Combination; Humans; Hypotension; Male; Myocardial Infarction; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 1999 |
Should male patients with chest pain be questioned about Viagra use during triage screening?
Topics: Adult; Chest Pain; Drug Interactions; Humans; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tachycardia, Ventricular; Triage; Vasodilator Agents | 2001 |
Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adenoviruses, Human; Animals; beta-Galactosidase; Cyclic GMP; Drug Synergism; Endothelial Growth Factors; Gene Transfer Techniques; Genes, Reporter; Genetic Vectors; Guanylate Cyclase; Heart; Humans; Isoquinolines; Lymphokines; Myocardium; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Phosphodiesterase Inhibitors; Piperazines; Purines; Purinones; Pyridines; Rabbits; Sildenafil Citrate; Sulfones; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Nitrates and Viagra can be a deadly combination.
Topics: Coronary Circulation; Drug Synergism; Humans; Hypotension; Isosorbide Dinitrate; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2001 |
A new suicide.
Topics: Aged; Angina Pectoris; Drug Synergism; Emergency Treatment; Family Practice; Fatal Outcome; Humans; Male; Malingering; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Suicide; Sulfones; Vasodilator Agents | 2001 |
Ask the doctor. A few years ago, I had a heart attack. My doctor treated me with angioplasty, and I haven't had any symptoms of heart disease since. I do carry a bottle nitroglycerin with me, but haven't taken any in years. I renew my prescription every s
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Drug Synergism; Humans; Hypotension; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2001 |
KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dogs; Dose-Response Relationship, Drug; Imidazoles; Isoenzymes; Kinetics; Molecular Structure; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Platelet Aggregation Inhibitors; Purines; Quinazolines; Rabbits; Sildenafil Citrate; Sulfones | 2001 |
Sildenafil (Viagra) augments sodium nitroprusside-induced but not nitroglycerin-induced hypotension in dogs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cyclic GMP; Dogs; Drug Synergism; Female; Hypotension; Male; Nitroglycerin; Nitroprusside; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2002 |
Potential for use of pulse wave analysis in determining the interaction between sildenafil and glyceryl trinitrate.
Topics: Administration, Cutaneous; Blood Pressure; Diastole; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Heart Rate; Humans; Middle Aged; Nitroglycerin; Piperazines; Pulsatile Flow; Pulse; Purines; Sildenafil Citrate; Sphygmomanometers; Sulfones; Systole; Time Factors; Vasodilator Agents | 2002 |
Erection, erectile dysfunction: what has heart got to do with it?
Topics: Contraindications; Drug Interactions; Erectile Dysfunction; Hemodynamics; Humans; Male; Myocardial Infarction; Nitroglycerin; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2003 |
[A dangerous cocktail mixing the new anti-impotence pills and nitroglycerin].
Topics: Antihypertensive Agents; Contraindications; Drug Interactions; Hemodynamics; Humans; Male; Nitroglycerin; Piperazines; Purines; Risk Factors; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2004 |
Selective reversal of hyperglycemia-evoked gastric myoelectric dysrhythmias by nitrergic stimulation in healthy humans.
Topics: Adult; Blood Glucose; Constriction; Female; Gastrointestinal Motility; Humans; Hyperglycemia; Male; Middle Aged; Nitroglycerin; Ovum; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2005 |
Phosphodiesterase type 5 inhibitor sildenafil citrate does not potentiate the vasodilative properties of nebivolol in rat aorta.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Aorta, Thoracic; Benzopyrans; Cyclic Nucleotide Phosphodiesterases, Type 5; Ethanolamines; In Vitro Techniques; Isometric Contraction; Male; Nebivolol; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2006 |
I have a heart condition. Is it OK for me to take Viagra (sildenafil)?
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Contraindications; Humans; Male; Nitroglycerin; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2005 |
Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits.
Topics: Animals; Imidazoles; Male; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Nitroglycerin; Piperazines; Potassium Channels; Purines; Rabbits; Sildenafil Citrate; Sulfones; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2007 |
Are nitrates safe in patients who use sildenafil? Maybe.
Topics: Coronary Disease; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2007 |
Effects of combined sildenafil-nitric oxide donor on defibrillation efficacy.
Topics: Animals; Electric Countershock; Heart Ventricles; Hemodynamics; Myocardium; Nitric Oxide; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Swine; Ventricular Fibrillation | 2007 |
Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
Topics: Animals; Carbolines; Drug Evaluation, Preclinical; Enzyme Inhibitors; Guanylate Cyclase; Imidazoles; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitroglycerin; Oxadiazoles; Penile Erection; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Quinoxalines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2009 |
Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.
Topics: Cyclic GMP; Drug Therapy, Combination; Heart Failure; Humans; Hypertension, Pulmonary; Isosorbide Dinitrate; Male; Middle Aged; Nitro Compounds; Nitroglycerin; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents | 2009 |
ALERT: Revatio is another brand name for sildenafil.
Topics: Canada; Contraindications; Drug Interactions; Female; Humans; Hypertension, Pulmonary; Medication Errors; Medication Systems; Middle Aged; Myocardial Ischemia; Nitroglycerin; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2009 |
Sildenafil and glyceryl trinitrate reduce tactile allodynia in streptozotocin-injected rats.
Topics: Administration, Cutaneous; Analgesics; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Ganglia, Spinal; Gene Expression Regulation, Enzymologic; Hyperalgesia; Isoenzymes; Male; Nitric Oxide Donors; Nitroglycerin; Pain Measurement; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Posterior Horn Cells; Purines; Rats; Rats, Wistar; RNA, Messenger; Sildenafil Citrate; Streptozocin; Sulfones; Time Factors; Touch | 2010 |
Role of Ser102 and Ser104 as regulators of cGMP hydrolysis by PDE5A.
Topics: Amino Acid Substitution; Calcitonin Gene-Related Peptide; Catalytic Domain; Cell Line; Cilostazol; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; In Vitro Techniques; Models, Molecular; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Serine; Sildenafil Citrate; Sulfonamides; Sumatriptan; Tetrazoles | 2014 |
Botulinum toxin for treatment of Raynaud phenomenon in CREST syndrome.
Topics: Acetylcholine Release Inhibitors; Administration, Topical; Aged; Botulinum Toxins; CREST Syndrome; Diltiazem; Female; Humans; Nitroglycerin; Pain; Raynaud Disease; Sildenafil Citrate; Treatment Failure; Ulcer; Vasodilator Agents | 2018 |
The Effects of Sildenafil and/or Nitroglycerin on Random-pattern Skin Flaps After Nicotine Application in Rats.
Topics: Animals; Apoptosis; Cell Proliferation; Drug Design; Ischemia; Male; Microscopy, Electron, Transmission; Nicotine; Nitroglycerin; Ointments; Random Allocation; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Skin; Skin Transplantation; Surgical Flaps; Vasodilator Agents | 2020 |